Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
83.60 EUR | +1.52% |
|
-3.01% | +19.12% |
07-10 | KNORR-BREMSE : Receives a Sell rating from Barclays | ZD |
07-08 | KNORR-BREMSE : UBS remains its Buy rating | ZD |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 6.23B | 6.79B | 7.25B | 8.04B | 8B | |||||
Total Revenues | 6.23B | 6.79B | 7.25B | 8.04B | 8B | |||||
Cost of Goods Sold, Total | 3.07B | 3.43B | 3.85B | 4.15B | 3.89B | |||||
Gross Profit | 3.17B | 3.36B | 3.41B | 3.89B | 4.11B | |||||
Selling General & Admin Expenses, Total | 1.54B | 1.65B | 1.82B | 1.99B | 2.06B | |||||
Depreciation & Amortization - (IS) | 269M | 282M | 305M | 332M | 359M | |||||
Other Operating Expenses | 517M | 534M | 555M | 676M | 885M | |||||
Other Operating Expenses, Total | 2.33B | 2.46B | 2.68B | 3B | 3.3B | |||||
Operating Income | 841M | 896M | 733M | 886M | 809M | |||||
Interest Expense, Total | -66.8M | -56.49M | -50.82M | -101M | -107M | |||||
Interest And Investment Income | 19.35M | 15.9M | 49.13M | 31.91M | 60M | |||||
Net Interest Expenses | -47.45M | -40.59M | -1.69M | -69.11M | -47M | |||||
Income (Loss) On Equity Invest. | -1.99M | -2.34M | -10.98M | -19.6M | -16M | |||||
Currency Exchange Gains (Loss) | -18.15M | 15.38M | -19.94M | 10.41M | -9M | |||||
Other Non Operating Income (Expenses) | -105K | 7.16M | 11.98M | -4.81M | -19M | |||||
EBT, Excl. Unusual Items | 773M | 876M | 712M | 803M | 718M | |||||
Restructuring Charges | - | -11.1M | - | - | - | |||||
Merger & Related Restructuring Charges | -2.83M | -817K | -2.44M | - | - | |||||
Impairment of Goodwill | - | - | - | - | -1M | |||||
Gain (Loss) On Sale Of Investments | - | - | -2.89M | - | - | |||||
Gain (Loss) On Sale Of Assets | -2.83M | 16.77M | -10.84M | -21.89M | -62M | |||||
Asset Writedown | -24.36M | -8.41M | -19.67M | -18.74M | -32M | |||||
Insurance Settlements | 7.23M | 8.67M | 12.31M | 10.25M | 22M | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 751M | 881M | 689M | 773M | 645M | |||||
Income Tax Expense | 218M | 233M | 183M | 197M | 168M | |||||
Earnings From Continuing Operations | 532M | 647M | 506M | 576M | 477M | |||||
Net Income to Company | 532M | 647M | 506M | 576M | 477M | |||||
Minority Interest | -36.67M | -26.06M | -18.58M | -23.68M | -32M | |||||
Net Income - (IS) | 495M | 621M | 488M | 553M | 445M | |||||
Net Income to Common Incl Extra Items | 495M | 621M | 488M | 553M | 445M | |||||
Net Income to Common Excl. Extra Items | 495M | 621M | 488M | 553M | 445M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.07 | 3.85 | 3.03 | 3.43 | 2.76 | |||||
Basic EPS - Continuing Operations | 3.07 | 3.85 | 3.03 | 3.43 | 2.76 | |||||
Basic Weighted Average Shares Outstanding | 161M | 161M | 161M | 161M | 161M | |||||
Net EPS - Diluted | 3.07 | 3.85 | 3.03 | 3.43 | 2.76 | |||||
Diluted EPS - Continuing Operations | 3.07 | 3.85 | 3.03 | 3.43 | 2.76 | |||||
Diluted Weighted Average Shares Outstanding | 161M | 161M | 161M | 161M | 161M | |||||
Normalized Basic EPS | 2.77 | 3.23 | 2.65 | 2.97 | 2.59 | |||||
Normalized Diluted EPS | 2.77 | 3.23 | 2.65 | 2.97 | 2.59 | |||||
Dividend Per Share | 1.52 | 1.85 | 1.45 | 1.64 | 1.75 | |||||
Payout Ratio | 58.56 | 39.44 | 61.15 | 42.3 | 59.33 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.02B | 1.08B | 919M | 1.08B | 1.02B | |||||
EBITA | 856M | 910M | 749M | 905M | 828M | |||||
EBIT | 841M | 896M | 733M | 886M | 809M | |||||
EBITDAR | 1.03B | 1.09B | 938M | 1.1B | 1.03B | |||||
Total Revenues (As Reported) | 6.22B | 6.83B | 7.28B | 8.03B | 8.04B | |||||
Effective Tax Rate - (Ratio) | 29.1 | 26.5 | 26.5 | 25.44 | 26.05 | |||||
Total Current Taxes | 183M | 212M | 205M | 185M | 223M | |||||
Total Deferred Taxes | 35.84M | 21.77M | -22.92M | 11.18M | -55M | |||||
Normalized Net Income | 447M | 521M | 427M | 478M | 417M | |||||
Interest on Long-Term Debt | 10.84M | 13.31M | 15.33M | 18.18M | 20M | |||||
Non-Cash Pension Expense | 4.16M | 3.39M | 3.27M | 7.2M | 8M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 320M | 348M | 361M | 437M | 73M | |||||
Net Rental Expense, Total | 15.11M | 12.67M | 19.3M | 21.24M | 18M | |||||
Imputed Operating Lease Interest Expense | 3.97M | 3.15M | 4.41M | 8.12M | 5.89M | |||||
Imputed Operating Lease Depreciation | 11.14M | 9.52M | 14.89M | 13.13M | 12.11M | |||||
Maintenance & Repair Expenses, Total | 93.14M | 90.78M | 111M | 130M | 129M |
- Stock Market
- Equities
- KBX Stock
- Financials Knorr-Bremse AG
- Income Statement
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition